Literature DB >> 6902770

Circulating prostaglandin E2 concentrations and patent ductus arteriosus in fetal and neonatal lambs.

R I Clyman, F Mauray, C Roman, A M Rudolph, M A Heymann.   

Abstract

We used pregnant sheep and their fetuses as well as newborn lambs (with and without severe respiratory distress due to prematurity) to study the differences in plasma clearance rate, production rate, and circulating concentrations of immunoreactive PGE2. Fetal PGE2 concentrations were significantly higher than simultaneous maternal concentrations. After delivery by cesarean section, all newborn animals were paralyzed and mechanically ventilated. The PGE2 concentrations fell in those lambs that required only minimal ventilatory support (FIO2 < 0.25) and were similar to maternal concentrations by two to three hours. Newborn lambs that developed severe respiratory distress (FIO2 < 0.55) continued to have concentrations that were even greater than fetal concentrations. The elevated PGE2 concentrations in severely distressed lambs were due not only to a decreased plasma clearance rate but also to an increased production rate of PGE2. Since PGE2 appears to maintain the patency of the ductus arteriosus in the fetus and preterm neonate, we examined the patency of the ductus arteriosus in 3-hour-old newborn lambs by radioactive microsphere injections. The ductus was more widely patent in lambs with higher concentrations of PGE2. The increased circulating concentrations of PGE2 in newborn lambs with severe respiratory distress may contribute to the pathogenesis of patent ductus arteriosus by exerting an additional vasodilatory effect on the vessel.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6902770     DOI: 10.1016/s0022-3476(80)80205-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus.

Authors:  Arya Mani; Seyed-Mahmoud Meraji; Roozbeh Houshyar; Jayaram Radhakrishnan; Alaleh Mani; Mehrabeh Ahangar; Tayebeh M Rezaie; Mohammad-Ali Taghavinejad; Behrooz Broumand; Hongyu Zhao; Carol Nelson-Williams; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

2.  Antenatal calcium channel blocker exposure and subsequent patent ductus arteriosus in extremely low-birth-weight infants.

Authors:  Jennifer McGuirl; Bonnie Arzuaga; Ben H Lee
Journal:  Pediatr Cardiol       Date:  2011-08-23       Impact factor: 1.655

3.  RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models.

Authors:  Nadine Haase; Donald J Foster; Mark W Cunningham; Julia Bercher; Tuyen Nguyen; Svetlana Shulga-Morskaya; Stuart Milstein; Sarfraz Shaikh; Jeff Rollins; Michaela Golic; Florian Herse; Kristin Kräker; Ivo Bendix; Meray Serdar; Hanna Napieczynska; Arnd Heuser; Alexandra Gellhaus; Kristin Thiele; Gerd Wallukat; Dominik N Müller; Babbette LaMarca; Ralf Dechend
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

4.  Hemodynamically significant PDA: an echocardiographic and clinical assessment of incidence, natural history, and outcome in very low birth weight infants maintained in negative fluid balance.

Authors:  M D Reller; J M Lorenz; U R Kotagal; R A Meyer; S Kaplan
Journal:  Pediatr Cardiol       Date:  1985       Impact factor: 1.655

Review 5.  The pharmacological treatment of patent ductus arteriosus. A review of the evidence.

Authors:  R J Barst; W M Gersony
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

6.  Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder.

Authors:  Arya Mani; Jayaram Radhakrishnan; Anita Farhi; Khary S Carew; Carole A Warnes; Carol Nelson-Williams; Ronald W Day; Barbara Pober; Matthew W State; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

7.  Interactions between indomethacin, noradrenaline and vasodilators in the fetal rabbit ductus arteriosus.

Authors:  G C Smith; J C McGrath
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice.

Authors:  Hee-Yoon Chang; Joseph Locker; Run Lu; Victor L Schuster
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

9.  Platelets contribute to postnatal occlusion of the ductus arteriosus.

Authors:  Katrin Echtler; Konstantin Stark; Michael Lorenz; Sandra Kerstan; Axel Walch; Luise Jennen; Martina Rudelius; Stefan Seidl; Elisabeth Kremmer; Nikla R Emambokus; Marie-Luise von Bruehl; Jon Frampton; Berend Isermann; Orsolya Genzel-Boroviczény; Christian Schreiber; Julinda Mehilli; Adnan Kastrati; Markus Schwaiger; Ramesh A Shivdasani; Steffen Massberg
Journal:  Nat Med       Date:  2009-12-06       Impact factor: 53.440

10.  Maturation of the contractile response of the Emu ductus arteriosus.

Authors:  Edward M Dzialowski; Henry Greyner
Journal:  J Comp Physiol B       Date:  2007-12-11       Impact factor: 2.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.